Prosecution Insights
Last updated: October 04, 2026

Sunnybrook Research Institute

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Analysis

Sunnybrook Research Institute has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 6 actions are distributed among 6 distinct examiners, meaning each pending matter is being handled by a different person. This distribution requires the institute to engage with six unique examiners, adapting its strategy to the specific preferences of each official.

The portfolio is active across 5 distinct art units. CWERN, JONATHAN is the busiest examiner for the company, currently managing 1 pending office action. Since each of the 6 examiners is responsible for exactly 1 action, the workload is evenly spread across the 5 art units and the assigned personnel. This lack of examiner overlap across the 6 actions means that the institute's success depends on the individual determinations of six different officials. Managing these diverse relationships across 5 art units is essential for the institute's biotechnology and pharmaceutical intellectual property goals.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

7
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (71%)
2
Medium (29%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (14%)
§103 only2 (29%)
Multi-statute (no §101)4 (57%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
43% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
43% of docket
1
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CWERN, JONATHAN 1 50.9% +33.3%
VIRK, ADIL PARTAP S 1 47.8% +43.0%
HAUSMANN, MICHELLE M 1 76.7% +21.1%
POHNERT, STEVEN C 1 12.4% +18.5%
BARRON, SEAN C 1 52.9% +30.9%
HUYNH, PHUONG N 1 65.7% +53.6%
DANG, ANH TIEU 1 65.5% +35.5%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18606200 CONSTRUCTS, USE AND METHODS THEREOF POHNERT, STEVEN C 14d
19147479 SYSTEMS AND METHODS FOR CONTROLLING TRANSDUCER MODULES FOR GENERATING FOCUSED ULTRASOUND CWERN, JONATHAN —
19225582 SYSTEMS AND METHODS FOR REDUCING THERMAL SKULL-INDUCED ABERRATIONS DURING TRANSCRANIAL ULTRASOUND THERAPEUTIC PROCEDURES VIRK, ADIL PARTAP S —
18287970 T CELLS COMPRISING AN UNREARRANGED T CELL RECEPTOR (TCR) GENE LOCUS AND METHODS OF USE THEREOF BARRON, SEAN C —
18029468 BISPECIFIC CONSTRUCTS FOR EXPANDING T CELLS AND RELATED METHODS HUYNH, PHUONG N —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18606200 CONSTRUCTS, USE AND METHODS THEREOF POHNERT, STEVEN C 14d
17608276 SYSTEMS AND METHODS FOR A BALLOON CATHETER SUPPORT SLEEVE DANG, ANH TIEU 55d
19147479 SYSTEMS AND METHODS FOR CONTROLLING TRANSDUCER MODULES FOR GENERATING FOCUSED ULTRASOUND CWERN, JONATHAN —
19225582 SYSTEMS AND METHODS FOR REDUCING THERMAL SKULL-INDUCED ABERRATIONS DURING TRANSCRANIAL ULTRASOUND THERAPEUTIC PROCEDURES VIRK, ADIL PARTAP S —
18856153 SYSTEMS AND METHODS FOR PERFORMING STAIN DECONVOLUTION HAUSMANN, MICHELLE M —
18287970 T CELLS COMPRISING AN UNREARRANGED T CELL RECEPTOR (TCR) GENE LOCUS AND METHODS OF USE THEREOF BARRON, SEAN C —
18029468 BISPECIFIC CONSTRUCTS FOR EXPANDING T CELLS AND RELATED METHODS HUYNH, PHUONG N —

Top Art Units

Art UnitApps
3797 1
3798 1
1683 1
1653 1
1641 1
3771 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19147479 SYSTEMS AND METHODS FOR CONTROLLING TRANSDUCER MODULES FOR GENERATING FOCUSED ULTRASOUND CWERN, JONATHAN 3797 §102§103 Non-Final OA — Pending Jul 11, 2025
19225582 SYSTEMS AND METHODS FOR REDUCING THERMAL SKULL-INDUCED ABERRATIONS DURING TRANSCRANIAL ULTRASOUND THERAPEUTIC PROCEDURES VIRK, ADIL PARTAP S 3798 §101§102§112 Non-Final OA — Pending Jun 02, 2025
18856153 SYSTEMS AND METHODS FOR PERFORMING STAIN DECONVOLUTION HAUSMANN, MICHELLE M — §103 Non-Final OA — Pending Oct 11, 2024
18606200 CONSTRUCTS, USE AND METHODS THEREOF POHNERT, STEVEN C 1683 §103§112 Final Rejection 14d Pending Mar 15, 2024
18287970 T CELLS COMPRISING AN UNREARRANGED T CELL RECEPTOR (TCR) GENE LOCUS AND METHODS OF USE THEREOF BARRON, SEAN C 1653 §102§112 Non-Final OA — Pending Oct 23, 2023
18029468 BISPECIFIC CONSTRUCTS FOR EXPANDING T CELLS AND RELATED METHODS HUYNH, PHUONG N 1641 §103§112 Final Rejection — Pending Mar 30, 2023
17608276 SYSTEMS AND METHODS FOR A BALLOON CATHETER SUPPORT SLEEVE DANG, ANH TIEU 3771 §103 Non-Final OA 55d Pending Nov 02, 2021

Managing Sunnybrook Research Institute's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month